Emily K. Sims
Biochemistry, Genetics and Molecular Biology · Indiana University
Diabetes and associated disordersPancreatic function and diabetesDiabetes Management and ResearchDiabetes Treatment and ManagementExtracellular vesicles in disease
Publications
240
Citations
4,605
Est. group size
~2
Recurring co-author estimate
Active years
32
Publishing since 1995
Publication cadence
Publications per year over the last 10 years — averaging 24.2/year recently
Recent publications
- Assessing extracellular vesicle proteins as predictive biomarkers for developing type 1 diabetes
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adults
medRxiv · 2026
- Going From Stage 2 to Stage 3 Type 1 Diabetes—Does Not Matter How You Got Here
Diabetes Care · 2026
- C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes
Diabetes Care · 2026
- Carbamylome analysis reveals regulatory roles for lysine carbamylation in β-cell glycolytic and insulin-processing enzymes
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Multi-omics data compendium of pancreatic islet and β cell responses to pro-inflammatory cytokines
Research Square · 2026
- Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study
Diabetes Care · 2025
- Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab
Diabetes Care · 2025
- IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
Diabetologia · 2025
- Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles
PROTEOMICS · 2025
- Teplizumab-mzwv: Perspective on clinical practice and use at a single institution
SMART-MD journal of precision medicine. · 2025
- Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
Diabetes · 2025
- Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes
Diabetes · 2025
- Proinflammatory Stress Activates Neutral Sphingomyelinase 2–Based Generation of a Ceramide-Enriched β-Cell EV Subpopulation
Diabetes · 2025
- Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval
Diabetes · 2025
Publishes in
- Diabetes×53
- Diabetes Care×19
- Diabetologia×12
- PMC×12
- bioRxiv (Cold Spring Harbor Laboratory)×9
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile